(Q54325984)

English

Semi-quantitative immunohistochemical assay versus oncotype DX(®) qRT-PCR assay for estrogen and progesterone receptors: an independent quality assurance study.

scientific article published on 3 February 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22301704

Semi-quantitative immunohistochemical assay versus oncotype DX(®) qRT-PCR assay for estrogen and progesterone receptors: an independent quality assurance study. (English)

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22301704

immunohistochemistry

1 reference

based on heuristic

inferred from title

author name string

James A Kraus

1

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22301704

David J Dabbs

2

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22301704

Sushil Beriwal

3

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22301704

Rohit Bhargava

4

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22301704

publication date

3 February 2012

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22301704

Modern Pathology

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22301704

25

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22301704

6

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22301704

869-876

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22301704

https://scigraph.springernature.com/pub.10.1038/modpathol.2011.219

0 references

American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

21 January 2018

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

21 January 2018

Concordance between semiquantitative immunohistochemical assay and oncotype DX RT-PCR assay for estrogen and progesterone receptors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

21 January 2018

Histopathologic variables predict Oncotype DX recurrence score

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

21 January 2018

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

21 January 2018

Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

21 January 2018

Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

21 January 2018

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

21 January 2018

Oestrogen receptor in breast cancer: prognostic studies using a new immunohistochemical assay

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

21 January 2018

Immunohistochemical evaluation of hormone receptor status for predicting response to endocrine therapy in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

21 January 2018

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

21 January 2018

Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

21 January 2018

Immunohistochemical assessment for estrogen receptor and progesterone receptor status in breast cancer: analysis for a cut-off point as the predictor for endocrine therapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

21 January 2018

Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

21 January 2018

Effect of delayed formalin fixation on estrogen and progesterone receptors in breast cancer: a study of three different clones

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

21 January 2018

Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

21 January 2018

Comparison of core oestrogen receptor (ER) assay with excised tumour: intratumoral distribution of ER in breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

21 January 2018

High false-negative rate of HER2 quantitative reverse transcription polymerase chain reaction of the Oncotype DX test: an independent quality assurance study.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

21 January 2018

A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

21 January 2018

Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

7 January 2021

based on heuristic

inferred from DOI database lookup

A simple index using video image analysis to predict disease outcome in primary breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

7 January 2021

based on heuristic

inferred from DOI database lookup

High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of estrogen receptor SP1 and 1D5 monoclonal antibodies in routine clinical use reveals similar staining results

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical Detection Using the New Rabbit Monoclonal Antibody SP1 of Estrogen Receptor in Breast Cancer Is Superior to Mouse Monoclonal Antibody 1D5 in Predicting Survival

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

7 January 2021

based on heuristic

inferred from DOI database lookup

Routine pathologic parameters can predict Oncotype DX recurrence scores in subsets of ER positive patients: who does not always need testing?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.219

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MODPATHOL.2011.219

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22301704

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22301704

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54325984&oldid=1456904006"